Presentation of Data at the North American Cystic Fibrosis Conference
Release Date: 10/10/2012 12:00am
Pharmaceutical company Pharmaxis (ASX: PXS) is pleased to announce that Bronchitol® is the subject of three presentations at the 26th annual North American Cystic Fibrosis Conference to be held in Orlando, Florida from October 10th – 13th. These presentations focus on new analyses of patient subgroups in the Phase 3 clinical trials.
The abstracts are available on the NACF conference website at: https://www.nacfconference.org/
Categories: News and Media